I hope the title of this post has caught your attention.
While the drug companies, the World Health Authority, the FDA and the MHRA all sit around and agree what ‘addiction’ means to them, in the real world we know the truth.
For hundreds of thousands of people around the world, Seroxat addiction is all too real.
You want to stop taking Seroxat, but when you try to stop, you find you can’t – the physical and mental withdrawal symptoms can include akathesia, agitation, mania, psychosis, self harm, suicidal thoughts and actions, violence, fear of loud noises, electric zaps of the head and body, thoughts of homicide, profuse sweating, disturbing nightmares, lack of empathy toward other people, anger, severe memory loss, nausea.
Not everyone who takes Seroxat will be affected – maybe 35%, maybe 40%, maybe 50%… the fact is that no one knows because Glaxo has never bothered to do any research into the level of Seroxat withdrawal problems nor any research into why some people suffer so badly.
The bottom line is Glaxo actually doesn’t care – it takes the line that there is no problem – Seroxat is safe and it’s easy to stop taking it.
However, having experienced Seroxat addiction myself, I can confirm how real the addiction is. As can the hundreds of people who have contacted me with their own horror stories.
Glaxo dismiss us – there is no place for ‘anecdotal’ evidence in their world – you see the experiences of real patients in the real world are based on personal accounts rather than facts or research. The thing is, that no matter if you’re from the UK, Europe, the USA, Australia or the Far East, the withdrawal stories are all the same. But Glaxo ignores the fact there is a problem and has NEVER bothered to undertake any research in Seroxat withdrawal symptoms.
Furthermore, Glaxo has never bothered to undertake any research into the best way to taper off Seroxat.
Of course you have to suspend disbelief in order to to take Glaxo’s ‘research’ seriously. Glaxo has a long history of rigging drug trials and hiding negative data when they apply for drug licences. Take the infamous Study 329.
In October 1998, an internal, confidential SmithKline Beecham document about studies 329 and 377 was issued. Studies 329 and 377 tried to prove Seroxat/Paxil worked in children. In summary it said “… the data do not support a label claim for the treatment of Adolescent Depression… efficacy had not been demonstrated.” Specifically about Study 329 “…the study failed to demonstrate a statistically significant difference from placebo on the primary efficacy measures.”
In other words – Seroxat didn’t work.
About Study 377 we read “… failed demonstrate [sic] any separation of Seroxat/Paxil from placebo.”
In other words – Seroxat didn’t work.
In March 1999, a fuller manuscript of Study 329 being prepared for publication. This was written by Sally K Laden but was attributed to Marty Keller, Neil Ryan and colleagues. The conclusion reads “Paroxetine is a safe and effective treatment of major depressive disorder in the adolescent patient.”
By March 2001, internally at least, SmithKline Beecham seem to have understood what the data from Study 329 really said. In an email to PR company Cohn and Wolfe, SKB said: “Originally we planned to do extensive media relations surrounding this study  until we viewed the results. essentially the study did not really show Paxil was effective in treating adolescent depression, which is not something we want to publicize.”
However, by August 2001 SmithKline Beecham Paxil Product Management was writing to all sales representatives selling paxil and telling them about Marty Keller’s “cutting edge, landmark study  which was the first to compare efficacy of an SSRI and a TCA with placebo in the treatment of major depression in adolescents. Paxil demonstrates REMARKABLE Efficacy and Safety in the treatment of adolescent depression.”
And Glaxo won’t listen to me and others but thinks I should take its ‘research’ seriously?
Over the years previously secrets documents have slowly come into the public domain which prove how shameful Glaxo has been in it’s lies about the efficacy and safety of Seroxat. Everytime there is a court case we find out a little more.
That’s why I’m looking forward to the High Court case in London and seeing all the previously secret documents that will no doubt become public over the course of the trial.
If you want to learn more, just type ‘Study 329’ into the search box on the left…